BAWEI
837023
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 15.69%763.59M | -60.25%128.83M | -58.75%234.41M | -20.37%430.73M | -18.26%660.04M | -21.87%324.11M | 21.32%568.27M | 40.27%540.95M | 139.33%807.46M | -6.98%414.84M |
Notes receivable and accounts receivable | -20.20%709.6M | -18.29%737.46M | -18.55%822.24M | -15.50%804.76M | -7.18%889.19M | 6.99%902.55M | -12.14%1.01B | -19.83%952.35M | -21.80%957.95M | -29.79%843.57M |
-Notes receivable | -51.39%2.68M | -48.07%2.97M | 2,502.85%1.59M | --2.69M | 454.79%5.51M | 439.00%5.71M | -97.74%60.99K | ---- | -95.17%992.5K | -94.98%1.06M |
-Accounts receivable | -20.00%706.92M | -18.10%734.5M | -18.71%820.66M | -15.78%802.07M | -7.66%883.68M | 6.45%896.83M | -11.94%1.01B | -18.59%952.35M | -20.55%956.96M | -28.62%842.51M |
Other receivables (including interest and dividends) | -80.63%15.7M | -78.83%16.9M | -21.36%16.77M | 99.36%51.97M | 256.98%81.04M | 31.16%79.84M | -74.82%21.33M | -66.84%26.07M | -69.79%22.7M | -55.52%60.87M |
-Other receivable | ---- | ---- | ---- | 99.36%51.97M | ---- | 31.16%79.84M | ---- | -66.84%26.07M | ---- | -55.52%60.87M |
Contractual assets | 331.50%2.78M | 421.45%3.36M | --645.18K | --645.18K | --645.18K | --645.18K | ---- | ---- | ---- | ---- |
Advance payment | -30.56%37.49M | -58.51%12.5M | -20.88%48.87M | 11.16%52.49M | -2.24%53.99M | 183.27%30.14M | -59.73%61.77M | -64.92%47.22M | -60.61%55.23M | -89.47%10.64M |
Inventories | -6.47%116.08M | -11.91%105.89M | -10.68%119.43M | 16.48%131.39M | -0.66%124.12M | -0.61%120.2M | -14.03%133.72M | -24.30%112.8M | -21.92%124.94M | -19.12%120.94M |
Receivable financing | -96.78%1.03M | -92.39%38.94K | -71.48%299.84K | 30.93%2.25M | 1,427.33%32.08M | -80.78%511.38K | -87.08%1.05M | -85.00%1.72M | -88.14%2.1M | -65.79%2.66M |
Non-current assets due within one year | -20.85%98.23M | -14.97%98.23M | 120.30%126.99M | 104.96%118.15M | 96.88%124.12M | 79.15%115.53M | -11.03%57.64M | -11.03%57.64M | 0.58%63.04M | 2.89%64.49M |
Other current assets | 19.89%84.63M | 15.53%75.72M | 59.16%71.7M | -25.73%67.34M | -15.07%70.59M | -12.01%65.54M | -40.26%45.05M | 33.96%90.67M | -6.87%83.12M | -16.18%74.48M |
Total current assets | -10.15%1.83B | -28.07%1.18B | -24.07%1.44B | -9.28%1.66B | -3.81%2.04B | 2.92%1.64B | -12.09%1.9B | -12.03%1.83B | 0.43%2.12B | -27.42%1.59B |
Non Current assets | ||||||||||
Other non-current financial assets | -44.57%88.51M | -31.74%88.51M | 5.52%156.86M | 5.52%156.86M | 10.79%159.66M | -9.92%129.66M | -11.09%148.65M | -16.11%148.65M | -19.52%144.11M | -19.62%143.93M |
Investment real estate | -2.78%33M | -2.76%33.23M | -2.74%33.47M | -2.72%33.7M | -2.70%33.94M | -2.69%34.18M | -2.67%34.41M | -2.65%34.65M | -2.63%34.88M | -2.62%35.12M |
Long-term equity investment | -8.81%42.74M | -8.81%43.34M | -3.25%45.68M | -2.81%46.23M | -7.65%46.87M | -66.58%47.53M | -72.12%47.22M | -71.78%47.57M | -70.37%50.75M | -17.28%142.19M |
Long term receivable account | 543.44%516.22M | 543.51%516.22M | -53.78%58.4M | -53.78%58.39M | -47.29%80.23M | -46.79%80.22M | -35.69%126.35M | -35.69%126.34M | -30.67%152.21M | -31.33%150.75M |
Fixed assets | ---- | ---- | ---- | 0.97%2.28B | ---- | 8.06%2.38B | ---- | 7.54%2.26B | ---- | --2.2B |
Constru in process | ---- | ---- | ---- | -12.95%767.37M | ---- | -9.86%696.72M | ---- | -4.88%881.54M | ---- | -1.67%772.89M |
Intangible assets | -6.27%520.02M | -6.24%529.54M | -53.38%537.44M | -53.37%544.71M | -48.49%554.83M | 10.22%564.77M | 185.45%1.15B | 210.92%1.17B | 187.02%1.08B | 34.14%512.41M |
Development expenditure | 96.44%44.28M | 169.09%41.6M | 125.63%26.8M | 85.49%26.26M | -26.02%22.54M | -30.44%15.46M | -24.85%11.88M | -48.79%14.16M | 8.12%30.47M | -4.43%22.23M |
Long deferred expense | 39.54%65.07M | 28.50%63.75M | 12.94%41.48M | 11.69%43.88M | -3.56%46.63M | 15.09%49.61M | 16.99%36.72M | 27.50%39.29M | 87.08%48.35M | 65.57%43.11M |
Deferred tax assets | 10.51%137.56M | 12.83%141.39M | -0.21%125.4M | 0.93%126.19M | -1.12%124.48M | 1.38%125.32M | 42.74%125.67M | 44.59%125.02M | 43.46%125.89M | 41.76%123.61M |
Usufruct assets | -35.84%50.8M | -36.30%52.56M | 46.87%92.55M | 49.66%97.27M | 17.91%79.18M | 19.05%82.52M | -11.39%63.02M | -11.53%64.99M | -11.42%67.15M | -11.31%69.32M |
Other non current assets | -91.94%54.48M | -91.81%54.75M | 807.19%658.71M | 825.37%671.91M | 300.07%675.79M | 214.31%668.92M | -73.70%72.61M | -72.05%72.61M | -18.83%168.92M | 2.27%212.82M |
Total non current assets | -4.11%4.67B | -5.01%4.63B | -2.69%4.82B | -2.58%4.85B | -0.73%4.87B | 10.02%4.88B | 10.08%4.95B | 11.73%4.98B | 10.54%4.9B | 1.40%4.43B |
Total assets | -5.89%6.5B | -10.81%5.81B | -8.61%6.26B | -4.37%6.51B | -1.66%6.9B | 8.15%6.52B | 2.89%6.85B | 4.17%6.81B | 7.29%7.02B | -8.23%6.03B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -41.00%698.2M | -27.58%517.61M | -33.60%646.57M | -7.64%886.62M | 13.50%1.18B | -26.04%714.75M | 0.99%973.78M | 23.69%959.97M | 53.20%1.04B | 85.01%966.36M |
Notes payable and accounts payable | 17.65%505.29M | 8.43%508.46M | 12.44%474.34M | 19.36%432.09M | 16.04%429.49M | 27.81%468.94M | 27.91%421.85M | 6.05%362M | -13.67%370.13M | -27.89%366.89M |
-Notes payable | 26.28%67.99M | -18.22%34.81M | 209.76%62.94M | 409.92%50.49M | 140.13%53.84M | 145.81%42.56M | 62.04%20.32M | 10.57%9.9M | 23.95%22.42M | 41.29%17.32M |
-Accounts payable | 16.41%437.29M | 11.09%473.65M | 2.46%411.41M | 8.38%381.6M | 8.04%375.65M | 21.97%426.37M | 26.57%401.53M | 5.93%352.1M | -15.33%347.7M | -29.59%349.58M |
Contract liabilities | 37.22%40.51M | -25.70%27.58M | 11.12%48.5M | 11.84%43.46M | -29.80%29.53M | 24.92%37.13M | 95.80%43.64M | 156.56%38.86M | 100.06%42.06M | 44.04%29.72M |
Salaries payable | -12.90%17.88M | -16.07%18.26M | -5.60%13.8M | 41.66%20.56M | -19.30%20.52M | -39.49%21.75M | 2.26%14.62M | -4.29%14.51M | 57.21%25.43M | 46.98%35.95M |
Taxs payable | -61.48%14.97M | -39.46%25.46M | -26.26%34.88M | -20.84%39.44M | -21.29%38.86M | -9.43%42.06M | -20.84%47.31M | -17.52%49.82M | -16.42%49.38M | -25.84%46.44M |
Other payable (including interest and dividends) | 129.02%35.56M | 36.27%20.97M | -3.49%16.66M | -13.83%16.33M | -60.58%15.53M | -55.61%15.39M | 0.40%17.26M | 5.76%18.95M | 181.10%39.39M | 121.48%34.67M |
-Other payable | ---- | ---- | ---- | -13.83%16.33M | ---- | -55.61%15.39M | ---- | 5.76%18.95M | ---- | --34.67M |
Non current liabilities due within one year | 87.42%555.75M | -14.85%324.58M | -19.49%326.09M | -22.67%317.13M | -15.85%296.52M | 30.91%381.18M | -35.88%405.06M | -39.03%410.11M | -22.05%352.39M | -43.80%291.17M |
Other current liabilities | 2,946.67%67.54M | 1,643.21%62.78M | 95.64%3.99M | 92.65%3.61M | -17.12%2.22M | 44.34%3.6M | 28.67%2.04M | 109.70%1.87M | 21.08%2.67M | 41.54%2.49M |
Total current liabilities | -3.98%1.94B | -10.63%1.51B | -18.73%1.56B | -5.22%1.76B | 4.78%2.02B | -5.01%1.68B | -5.65%1.93B | -2.29%1.86B | 14.95%1.92B | 5.93%1.77B |
Current liabilities | ||||||||||
Long term loan | 2.28%2.24B | -7.03%1.99B | -6.01%2.05B | -5.76%2.1B | -7.70%2.19B | 32.17%2.14B | 52.69%2.18B | 53.47%2.22B | 41.03%2.38B | -5.80%1.62B |
Long term account payable | ---- | ---- | ---- | --10.99M | ---- | --13.96M | ---- | ---- | ---- | ---- |
Estimate liabilities | ---- | ---- | 8.43%13.2M | 6.89%13.9M | -28.89%15.05M | -23.20%15.85M | -38.59%12.18M | -33.91%13.01M | -3.74%21.16M | -6.29%20.64M |
Deferred tax liabilities | -39.01%3.44M | -39.10%3.44M | 3.95%5.63M | 3.95%5.63M | 4.08%5.63M | 3.72%5.64M | -22.78%5.41M | -22.78%5.41M | -22.78%5.41M | -22.40%5.44M |
Long term deferred income | 44.40%40.42M | 11.85%32.94M | -3.14%30.41M | 3.32%26.74M | -2.28%27.99M | 25.98%29.45M | 37.35%31.4M | 9.29%25.88M | 18.27%28.64M | -10.73%23.38M |
Lease liabilities | -26.48%56.4M | -28.56%56.86M | 32.93%85.97M | 36.22%90.14M | 14.07%76.72M | 15.26%79.6M | -7.22%64.68M | -7.39%66.18M | -8.01%67.26M | -7.74%69.06M |
Other non current liabilities | ---- | ---- | -23.16%2.76M | -13.52%3.11M | -31.29%3.57M | -30.28%3.62M | -13.69%3.59M | -15.17%3.59M | 22.05%5.19M | 22.05%5.19M |
Total non current liabilities | 0.64%2.35B | -8.63%2.09B | -4.38%2.2B | -3.92%2.25B | -6.75%2.33B | 31.29%2.28B | 48.09%2.3B | 48.43%2.34B | 37.92%2.5B | -5.95%1.74B |
Total liabilities | -1.50%4.28B | -9.48%3.59B | -10.92%3.77B | -4.50%4.01B | -1.74%4.35B | 12.96%3.97B | 17.58%4.23B | 20.71%4.19B | 26.90%4.43B | -0.31%3.51B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%614.36M | 0.00%614.36M | 0.00%614.36M | 0.00%614.36M | 0.00%614.36M | 0.00%614.36M | 0.00%614.36M | 0.00%614.36M | 0.00%614.36M | 0.00%614.36M |
Capital reserve funds | 2.06%2.29B | 2.08%2.29B | 1.90%2.24B | 1.96%2.24B | 2.03%2.24B | 1.82%2.24B | 0.61%2.2B | 0.70%2.2B | 0.76%2.2B | 0.58%2.2B |
Surplus reserve funds | 0.00%36.44M | 0.00%36.44M | 0.00%36.44M | 0.00%36.44M | 0.00%36.44M | 0.00%36.44M | 0.00%36.44M | 0.00%36.44M | 0.00%36.44M | 0.00%36.44M |
Retained profit | -96.82%-789.55M | -93.82%-782.83M | -53.13%-460.71M | -46.48%-442.88M | -29.52%-401.15M | -21.71%-403.89M | -232.33%-300.87M | -228.51%-302.36M | -235.83%-309.73M | -261.52%-331.85M |
Less:Treasury stock | --9.71M | --9.71M | --9.71M | --9.71M | ---- | ---- | ---- | ---- | ---- | ---- |
Other composite income | -0.15%2.89M | -0.03%2.89M | 2.61%2.88M | 1.77%2.89M | 1.68%2.89M | -0.66%2.89M | 18.60%2.81M | 7.99%2.84M | -2.78%2.84M | 2.14%2.91M |
Shareholders equity without minority interests | -14.10%2.14B | -13.73%2.15B | -5.00%2.43B | -4.20%2.44B | -1.84%2.49B | -1.27%2.49B | -16.77%2.55B | -16.99%2.55B | -17.02%2.54B | -17.21%2.52B |
Minority interests | 17.40%70.16M | 24.96%69.29M | -1.16%69.41M | -3.34%64.79M | 14.25%59.76M | 570.42%55.45M | 1,592.53%70.23M | 903.59%67.03M | 811.38%52.31M | -85.13%-11.79M |
Total shareholder equity | -13.37%2.21B | -12.89%2.22B | -4.90%2.49B | -4.18%2.51B | -1.52%2.55B | 1.41%2.55B | -14.35%2.62B | -14.58%2.62B | -15.11%2.59B | -17.42%2.51B |
Total liabilityies and equity | -5.89%6.5B | -10.81%5.81B | -8.61%6.26B | -4.37%6.51B | -1.66%6.9B | 8.15%6.52B | 2.89%6.85B | 4.17%6.81B | 7.29%7.02B | -8.23%6.03B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Adverse Opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.